胰高血糖素样肽在重症患者血糖控制中的作用
被引量:5
摘要
ICU中的重症患者常合并应激性高血糖,血糖显著升高是危重症患者死亡的独立危险因素,重症患者中合并应激性高血糖的患者甚至较既往有糖尿病史的患者有更高的死亡率[1]。最近10年来,应用外源性胰岛素强化控制血糖显著降低了外科重症患者的术后感染率和多脏器功能障碍的发生率[2-3]。但是,也有越来越多的研究显示强化胰岛素治疗过程中低血糖事件的发生率显著增加而影响患者预后[4-5]。
出处
《中华医学杂志》
CAS
CSCD
北大核心
2011年第17期1222-1224,共3页
National Medical Journal of China
参考文献27
-
1Norhammar AM,Rydén L,Malmberg K.Admission plasma glucose:independent risk factor for long-term prognosis after myocardial infarction even in nondiabceic patients.Diabetes Care,1999,22:1827-1831.
-
2Van den Berghe G,Wouters P,Weekers F,et al.Intensive insulin therapy in critically ill patients.N Engl J Med,2001,345:1359-1367.
-
3Krinsley JS.Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.Mayo Clin Proc,2004,79:992-1000.
-
4Brunkhorst FM,Engel C,Bloos F,et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N Engl J Med,2008,358:125-139.
-
5Preiser JC,Devos P,Ruiz-Santana S,et al.A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units:the Glucontrol study.Intensive Care Med,2009,35:1738-1748.
-
6Deane AM,Chapman MJ,Fraser B J,et al.The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill:a randomized doubleblind placebo-controlled cross over study.Crit Care,2009,13:67.
-
7Hoist JJ.The physiology of gheagon-like peptide 1.Physiol Bey,2007,87:1409-1439.
-
8Elabi D.Glucagun-like peptide-1 (9-36) amide,cleavage product of glucagon-like peptide-1 (7-36) is a glucoregulatory peptide.Obesity,2008,16:1501-1509.
-
9Tomas E,Habener JF.Insulin-like actions of glucagon-like peptide-1:a dual receptor hypothesis.Trends in Endocrin Metabol,2010,21:59-67.
-
10Little TJ,Pilichiewicz AN,Russo A,et al.Effects of intravenous glucagnn-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects:relation.ships with postprandial glycemic and in sulinemic responses.J Clin Endocrinol Metab,2006,91:1916-1923.
同被引文献36
-
1曹相原,王晓红,马少林,杨晓军,王晓麒,丁欢,柳明,何兰杰,马晓薇,马希刚.应激性高糖血症与胰岛素抵抗的相关因素研究[J].中国危重病急救医学,2006,18(12):751-754. 被引量:41
-
2Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia [J] Lancet, 2009, 373 (9677):1798-1807.
-
3Toft-Nielsen MB, Damholt MB, Madsbad S, et al. Determi- nants of the impaired secretion of glucagon- like peptide- 1 in type 2 diabetic patients [J]. J Glln Endocrinol Metab, 2001, 86 (6) :3717-3723.
-
4Martindale RG, McClave SA, Vanek VW, et al. Guideiines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition : exec- utive summary [ J ]. Crit Care Med, 2009, 37 (5): 1757-1761.
-
5Zauner A, Nimmerrichter P, Anderwald C, et al. Severity of insulin resistance in critically ill medical patients [J]. Metabo- lism, 2007, 56 (1) : 1-5.
-
6VilsbcU T, Krarup T, Deacon CF, et ai. Reduced postprandi- al concentrations of intact biologically active glucagon-like pep- tide 1 in type 2 diabetic patients [ J]. Diabetes, 2001, 50 (3) :609-613.
-
7Vollmer K, Hoist JJ, Bailer B, et ai. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance [J]. Diabetes, 2008, 57 (3):678-687.
-
8Padwal R. Glucagon-like peptide-1 agonists [ J ]. BMJ, 2012, 344 :d7282.
-
9Deane AM, Chapman M J, Fraser RJ, et al. The effect of exog- enous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill : a randomized double- blind placebo-controlled cross over study [J]. Crit Care, 2009, 13 (3) :R67.
-
10Nauck MA, E1-Ouaghlidi A, Gabrys B, et, al. Secretion of incretin hormones ( GIP and GLP- 1 ) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes [J]. Regul Pept, 2004, 122 (3) :209-217.
引证文献5
-
1赵慧颖,李晓岚,吕杰,安友仲.手术应激对外科重症患者肠内和肠外葡萄糖负荷后血浆胰高血糖素样肽-1的影响[J].中华临床营养杂志,2013,21(3):157-162. 被引量:7
-
2申晶慧,仲维华.血糖水平对ICU危重症患者感染及预后的影响[J].糖尿病新世界,2015,35(21):126-128. 被引量:2
-
3刘曙艳,杨波.52例糖尿病合并横纹肌溶解症临床预后分析[J].社区医学杂志,2017,15(24):35-36.
-
4孙月玲.重症感染合并应激性高血糖患者短期强化血糖控制效果研究[J].河北医药,2018,40(1):10-13. 被引量:4
-
5刘曙艳,周雪红,陈洁.胰岛素泵强化治疗糖尿病并重症肺部感染及对血清和肺泡灌洗液中炎症因子的影响[J].中国现代医学杂志,2018,28(3):107-112. 被引量:35
二级引证文献48
-
1包小丽,李远辉,刘暖林,郭腾洲,汤步階,石波,何伟豪,雷诗敏.短期强化血糖控制对重症感染合并应激性高血糖患者血糖变异性及预后的影响[J].实用妇科内分泌电子杂志,2020,7(35):192-193.
-
2安晓菲,辛云辉.不同血糖水平对ICU危重症患者预后及感染的影响重点分析[J].糖尿病天地,2018,15(9):146-147.
-
3汪东兴.2型糖尿病胰岛素泵强化治疗48例疗效观察[J].糖尿病天地,2018,15(7):96-97.
-
4商艳朝.不同血清胰岛素水平对儿科重症监护病房患儿的影响[J].贵阳医学院学报,2014,39(4):560-562. 被引量:1
-
5袁向尚.PICU患儿血清胰岛素水平变化及其临床意义[J].中国实用医药,2014,9(28):60-61.
-
6张鑫,王锦波.应激与糖尿病的研究进展[J].中华灾害救援医学,2016,4(1):46-49. 被引量:2
-
7王旭升,吴志松,盛海忠,范文君,董巧稚,王彤,林谦.中西医结合治疗脓毒症合并应激性高血糖的研究进展[J].中西医结合心脑血管病杂志,2017,15(2):182-184. 被引量:5
-
8卞惟炜,陈运佑,王梦.硬膜外联合全身麻醉在老年腹部手术中的应用[J].中国中西医结合外科杂志,2017,23(1):40-43. 被引量:13
-
9张婷,张家隆,王永红,苏海华.利格列汀联合二甲双胍治疗初诊2型糖尿病的效果观察[J].中国处方药,2017,15(7):68-69. 被引量:10
-
10刘增超,张贵萍,赵慧娟,张宁,程浩.糖皮质激素联合胰岛素泵对慢性阻塞性肺疾病急性期合并糖尿病患者临床疗效及炎性指标和肺功能的影响[J].微循环学杂志,2018,28(2):23-28. 被引量:9
-
1刘玉梅,颜奎香,潘宝安.强化血糖管理对住院患者的影响[J].中国实用医药,2008,3(18):186-188.
-
2邢晓敏,苏乐群.二肽基肽酶Ⅳ抑制剂治疗2型糖尿病肥胖患者的临床研究进展[J].中国药房,2015,26(5):715-718. 被引量:7
-
3何素兰,李慧敏.浅谈安全使用胰岛素的管理[J].医学理论与实践,2011,24(20):2524-2525. 被引量:2
-
4戎敏之.前列腺素E_1用于糖尿病肾病患者的观察与护理[J].护士进修杂志,2002,17(4):286-288.
-
5王蔓莉,王凯丽,于长颖,李丹,张浩,张毅,姚磊.胃癌术后早期经鼻空肠营养管肠内营养患者的强化护理的临床效应[J].现代生物医学进展,2014,14(29):5758-5760. 被引量:8
-
6林乐乙.如何用好胰岛素这把双刃剑[J].糖尿病天地,2015,0(8):34-35.
-
7李传爱,张东,黄俊杰.110例患者TPN治疗体会[J].齐鲁护理杂志,1999,5(3):26-27.
-
8赵海涛,陆燕,陈玉林.重组人生长激素对烧伤病人糖代谢的影响[J].北京军区医药,2001,13(6):390-390. 被引量:7
-
9王翠霞.对待胰岛素的几个不能[J].糖尿病新世界,2012(6):40-41.
-
10石凯.乳腺导管内乳头状瘤在核磁共振中的诊断价值[J].世界最新医学信息文摘,2016,0(9):160-160. 被引量:1